2019
DOI: 10.1080/08820139.2019.1624770
|View full text |Cite
|
Sign up to set email alerts
|

Devil Facial Tumours: Towards a Vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 82 publications
0
10
0
Order By: Relevance
“…The release of captive-bred, immunised devils into local populations has been previously suggested to be a viable option in reducing DFTD spread [37]. Devils have been injected with sonicated DFTD cells with the aim to stimulate adaptive immunity as a potential vaccine [58], however, there is no evidence that attempted immunizations are prophylactic in the wild [59,60]. Furthermore, empirical and theoretical evidence suggest that vaccinations that do not prevent transmission and spread of disease (often referred to as leaky or imperfect vaccines) can create ecological and epidemiological conditions that would allow more virulent pathogen strains to emerge and persist [61,62].…”
Section: Discussionmentioning
confidence: 99%
“…The release of captive-bred, immunised devils into local populations has been previously suggested to be a viable option in reducing DFTD spread [37]. Devils have been injected with sonicated DFTD cells with the aim to stimulate adaptive immunity as a potential vaccine [58], however, there is no evidence that attempted immunizations are prophylactic in the wild [59,60]. Furthermore, empirical and theoretical evidence suggest that vaccinations that do not prevent transmission and spread of disease (often referred to as leaky or imperfect vaccines) can create ecological and epidemiological conditions that would allow more virulent pathogen strains to emerge and persist [61,62].…”
Section: Discussionmentioning
confidence: 99%
“…DFT2 has 3,591 SNVs and 572 insertions/deletions, but only 19 non-synonymous mutations. Short peptides that contain the non-synonymous portion of the protein could be used as alternative targets to full-length recombinant proteins [51]. A recent discovery that aberrantly expressed proteins from non-coding regions can function as tumor-specific antigens [52] is another possibility worth exploring.…”
Section: Recombinant Protein-based Vaccinementioning
confidence: 99%
“…In a first paper, Young Zen (2019) explores the generation of splicing variants of a serine protease homolog known to be important for tumor invasion in an invertebrate arthropod (the Crayfish, Procambarus clarkii). This is followed by two papers (Li et al, 2019;Owen and Siddle, 2019) concerning the interesting case of the Devil Facial Tumor Disease (DFTD) that plague the Tasmanian Devil, a mammalian species of Tasmania. This is a fatal monophyletic clonally transmissible cancer type that spreads between devils by biting during fights for mating.…”
Section: Introduction Jacques Robertmentioning
confidence: 99%
“…Given the MHC class I deficiency interfering with anti-DFTD tumor CD8 T cell cytotoxicity, the possible role of antibodymediated phagocytosis is a potentially relevant mechanism to explore. The second paper by Owen and Siddle (2019) is a comprehensive and timely review on the Devil facial tumors emphasizing the recent progress in anti-DFTP vaccine development. The review also provides an update of a second more recently discovered transmissible cancer in Tasmanian Devils (DFDT2).…”
Section: Introduction Jacques Robertmentioning
confidence: 99%